Detailed information for compound 69493

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 362.46 | Formula: C21H30O5
  • H donors: 1 H acceptors: 4 LogP: 2.23 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCC(=O)/C=C/[C@]1(O)CC(=O)C=C1C/C=C\CCCC(=O)OC
  • InChi: 1S/C21H30O5/c1-3-4-7-11-18(22)13-14-21(25)16-19(23)15-17(21)10-8-5-6-9-12-20(24)26-2/h5,8,13-15,25H,3-4,6-7,9-12,16H2,1-2H3/b8-5-,14-13+/t21-/m0/s1
  • InChiKey: HXAOERUKSRSNKN-UDBMEKHUSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) kinesin-like protein KLP2 0.0427 0.1284 1
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.001 0.0015 0.0079
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0007 0.0004 0.0005
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0034 0.0085 1
Loa Loa (eye worm) hypothetical protein 0.001 0.0015 0.0079
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0036 0.0093 0.0088
Schistosoma mansoni voltage-gated potassium channel 0.0039 0.0103 0.0118
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0007 0.0004 0.0005
Echinococcus granulosus potassium voltage gated channel subfamily H 0.001 0.0015 0.001
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0007 0.0004 0.0005
Brugia malayi Kinesin motor domain containing protein 0.0427 0.1284 1
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0007 0.0004 0.0005
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0034 0.0085 1
Entamoeba histolytica kinesin, putative 0.0427 0.1284 0.5
Loa Loa (eye worm) hypothetical protein 0.0031 0.0078 0.0576
Schistosoma mansoni voltage-gated potassium channel 0.001 0.0015 0.0017
Schistosoma mansoni voltage-gated potassium channel 0.0039 0.0103 0.0118
Echinococcus multilocularis kinesin family 1 0.329 1 1
Schistosoma mansoni voltage-gated potassium channel 0.0007 0.0004 0.0005
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.001 0.0015 0.001
Echinococcus multilocularis voltage gated potassium channel 0.001 0.0015 0.001
Echinococcus granulosus voltage gated potassium channel 0.001 0.0015 0.001
Schistosoma mansoni voltage-gated potassium channel 0.001 0.0015 0.0017
Plasmodium falciparum kinesin-5 0.0427 0.1284 0.5
Giardia lamblia Kinesin-5 0.0427 0.1284 0.5
Schistosoma mansoni kinesin eg-5 0.0427 0.1284 0.1476
Schistosoma mansoni hypothetical protein 0.2863 0.8699 1
Plasmodium vivax kinesin-5 0.0427 0.1284 0.5
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0036 0.0093 0.0088
Toxoplasma gondii kinesin motor domain-containing protein 0.0427 0.1284 0.5
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0036 0.0093 0.069
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0007 0.0004 0.0005
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0036 0.0093 0.069

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 6.6 uM In vitro antiproliferative activity of the compound was measured on human leukemia K562 cells ChEMBL. No reference
IC50 (functional) = 6.6 uM In vitro antiproliferative activity of the compound was measured on human leukemia K562 cells ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.